Healthcare >> CEO Interviews >> November 3, 2003
ROBERT L. FOLDES is President and Chief Executive Officer of Cytochroma
Inc. Prior to joining Cytochroma in August 2000, Dr. Foldes was
Director, Research Business Development at The Hospital for Sick
Children (HSC). During his three years at HSC, he established its
Intellectual Property and Commercial Development Office as a leader in
technology transfer and academic-industry partnering. Prior to joining
HSC, Dr. Foldes spent seven years with Allelix Biopharmaceuticals Inc.,
becoming Manager of Business Development, and helped to secure several
strategic alliances with pharmaceutical and biotechnology companies. Dr.
Foldes received his BSc from the University of Toronto in 1982, PhD in
Pharmacology from the University of Nebraska Medical Center in 1986 and
MBA from York University in Toronto in 1994. Dr. Foldes has a successful
track record in business and corporate development, equity financing,
technology management and development and the establishment and
management of successful commercialization partnerships. He has
negotiated licensing deals with academia and both small and large
companies, for a wide range of technologies including those relating to
therapeutics, drug screening, methods of treatment and reagents. Profile
an overview of what the company is doing at the present time?
Dr. Foldes: Cytochroma is a privately held company. It was
